Completed PHASE3 INTERVENTIONAL 2-arm NCT00727519

The Effect of Pomegranate Juice on Oxidative Stress in Hemodialysis Patients

A Randomized Clinical Trial for Estimating the Effects of Pomegranate Juice Consumption by Hemodialysis Patients on Oxidative Stress, Infections, Cardiovascular Events and Mortality

Sponsor: Western Galilee Hospital-Nahariya

Conditions End Stage Renal Disease Hemodialysis

Interventions Placebo Pomegranate juice

Updated 5 times since 2017 Last updated: Mar 22, 2010 Started: Jul 31, 2008 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on End Stage Renal Disease and Hemodialysis, this trial is completed. The trial is conducted by Western Galilee Hospital-Nahariya and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Western Galilee Hospital-Nahariya

Data source: Western Galilee Hospital-Nahariya

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nahariya, Israel